Cosmo Pharmaceuticals N.V. (ETR:C43)

Germany flag Germany · Delayed Price · Currency is EUR
50.00
0.00 (0.00%)
Inactive · Last trade price on Apr 30, 2025
Market Cap826.85M
Revenue (ttm)266.79M
Net Income (ttm)133.24M
Shares Outn/a
EPS (ttm)8.12
PE Ratio6.21
Forward PEn/a
Dividend2.05 (3.94%)
Ex-Dividend DateJun 4, 2025
Volumen/a
Average Volume65
Open50.00
Previous Closen/a
Day's Range50.00 - 50.00
52-Week Range47.80 - 86.50
Betan/a
RSI34.20
Earnings DateJul 23, 2025

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V. focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delive... [Read more]

Industry Pharmaceutical Preparations
Founded 1997
Employees 322
Stock Exchange Deutsche Börse Xetra
Ticker Symbol C43
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.